Multiple Sclerosis Therapeutics Industry Future Developments 2026–2036
The rise in diagnosis rates, driven by improved awareness and advanced diagnostic technologies, is also contributing to this growth. Innovative disease-modifying therapies, such as oral medications, monoclonal antibodies, and cell-based therapies, are transforming treatment methods.